By genetic deletion or overexpression of Pten, we confirmed that Pten functions as a tumor suppressor in LSCs of CML, consistent with the role of Pten in LSCs of acute myeloid leukemia (AML) and progenitor cells of T-ALL progenitors. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.